LUNSUMIO

Manufacturer:

GENENTECH USA, INC.

Name:

LUNSUMIO

HCPCS Code Descriptor:

Injection, mosunetuzumab-axgb, 1 mg

Category:

J Code

HCPCS:

J9350

NDC(s):

50242-0159-01, 50242-0142-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

LUNSUMIO is a Oncology drug manufactured by GENENTECH USA, INC. and administered via the Intravenous route of administration. The J Code: J9350 is aligned to the drug LUNSUMIO.

LUNSUMIO is an anti-cancer medication that belongs to the drug classes B-cell lymphoma inhibitor and anti-CD20 monoclonal antibodies. This medication can be used to treat a specific cancer of the lymphatic system. It works by targeting B lymphocytes (B cells) and targeting the CD20 protein on the B cells and the CD3 protein on the T cells. LUNSUMIO is manufactured by Genentech USA and is aligned to the HCPCS code J9350. Patient assistance programs for this medication can be found through the Genentech Patient Foundation.